Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Journal De Chirurgie|October 29, 2008
[Management of superficial rectal cancers]J-B Bachet, S BenoistBulletin Du Cancer|December 8, 2009
[Rectal cancer and adjuvant chemotherapy: which conclusions?]J-B Bachet, P Rougier, A de Gramont, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 23, 2018
[Circulating tumour DNA: Current detection methods, use in radiotherapy and future development]J Castelli, L Cabel, F-C Bidard, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 8, 2011
Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested?L Benhaim, S Benoist, J B Bachet, et al.Acta Gastro-Enterologica Belgica|August 9, 2012
Molecular changes in pancreatic cancer: implications for molecular targeting therapyP Demetter, R Maréchal, L Verset, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 5, 2017
[How to manage a rectal cancer with synchronous liver metastases? A question of strategy]V Vendrely, M Terlizzi, F Huguet, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2012
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitorsL Peuvrel, C Bachmeyer, Z Reguiai, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 4, 2012
Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physiciansL Peuvrel, C Bachmeyer, Z Reguiai, et al.Clinics and Research in Hepatology and Gastroenterology|March 6, 2023
Trop-2 is a ubiquitous and promising target in pancreatic adenocarcinomaL Mas, J Cros, M Svrcek, et al.Computer Methods and Programs in Biomedicine|December 8, 2021
%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncologyE Charton, A Falcoz, E François, et al.Pageof 4